NANOSPHERE, INC. OPTION AWARD AGREEMENT (Cliff-vested, performance-accelerated) FOR NAME
Exhibit 10.7
NANOSPHERE, INC.
2007 LONG-TERM INCENTIVE PLAN
(Cliff-vested, performance-accelerated)
FOR
NAME
GRANT DATE:
1. A STOCK OPTION to acquire ______ shares (hereinafter referred to as “Shares”) of Common
Stock of Nanosphere, Inc. (hereinafter referred to as the “Company”) is hereby granted to NAME
(hereinafter referred to as the “Optionee”), subject in all respects to the terms and conditions of
the Nanosphere, Inc. 2007 Long-Term Incentive Plan (hereinafter referred to as the “Plan”) and such
other terms and conditions as are set forth herein. All capitalized terms used in the Agreement,
and not otherwise defined herein, shall have the meanings ascribed to them in the Plan.
2. The Option is intended to constitute an Incentive Stock Option under Section 422 of the
Internal Revenue Code of 1986.
3. The Option price as determined by the Committee is per Share. The
Option price may be paid in any one or a combination of cash, personal check, Shares already owned
for at least six (6) months or broker exercise notice.
| 4. | a. | The Option shall become exercisable on ; provided, that, the Option may become exercisable earlier than to the extent the performance milestones set forth on Exhibit A attached hereto have been met on the terms and conditions set forth on such Exhibit A. |
| b. | In the event of a Change of Control, the Option shall become immediately and fully exercisable. | ||
| c. | In the event the Optionee’s Continuous Service is terminated for any reason, the Optionee’s right to continued vesting ends upon such termination. If such termination is a result of the Optionee’s death or because the Optionee is Disabled, the Optionee or the Optionee’s beneficiary shall have the right to exercise this Option for a period of twelve months after the date of termination. If such termination is for any other reason, other than Cause, the Optionee’s right to exercise this Option shall terminate three months after termination of Continuous Service. | ||
| d. | In the event the Optionee’s Continuous Service is terminated for Cause, the Option shall be immediately forfeited and any amounts received pursuant to this Agreement shall be returned to the Company and the Option price shall be repaid to the Optionee. |
5. The Option may not be exercised if the issuance of Shares upon such exercise would
constitute a violation of any applicable federal or state securities law, or any other valid law or
regulation. As a condition to the exercise of the Option, the Optionee shall represent to the
Company that the Shares being acquired upon exercise of the Option are for investment and not with
a present view for distribution or resale, unless counsel for the Company is then of the opinion
that such a representation is not required under any applicable law, regulation or rule of any
governmental agency.
6. The Option may not be transferred in any manner except as provided under the Plan, and
generally may be exercised during the lifetime of the Optionee only by him/her. The terms of this
Option shall be binding upon the Optionee’s executors, administrators, heirs, assigns and
successors.
7. The Optionee hereby agrees that the Optionee shall be bound by Section 26(c) of the Plan
which provides for a market stand-off agreement in connection with any underwritten public offering
of the Company’s equity securities.
8. The Optionee acknowledges and agrees that upon exercise of the Option, he/she shall execute
and the Shares shall be subject to the provisions of any applicable agreement then in effect among
the Company and any of its stockholders regarding restrictions, limitations or conditions on
resales of shares of the Company’s stock.
9. The Option may not be exercised more than ten (10) years after the date indicated below and
may be exercised during such term only in accordance with the terms and conditions set forth in the
Plan.
10. The Committee shall make all determinations concerning rights to benefits under the Plan.
Dated: _____________, 2007
| Nanosphere, Inc. |
||||
| By: | ||||
| Name: | ||||
| Officer: | ||||
ATTEST:
The Optionee acknowledges that «heshe» has received a copy of the Plan and is familiar with
the terms and conditions set forth therein. The Optionee agrees to accept as binding, conclusive,
and final all decisions and interpretations of the Committee. As a condition of this Agreement,
the Optionee authorizes the Company to withhold from any regular cash compensation payable by the
Company any taxes required to be withheld under any federal, state or local law as a result of
exercising this Option.
Dated: _______________________, _____
| By: | ||||
| Optionee | ||||
2
Exhibit A
Corporate Performance Milestone for 2007 Cliff-Vested Options
Upon the achievement of each of the following corporate performance milestones, 25% of the Shares
issuable upon exercise of this Option shall immediately vest and become exercisable. As a
clarifying example, if Milestone 1 is achieved prior to April 3, 2014, 25% of the Shares issuable
upon exercise of this Option will vest. Subsequent to that achievement, if Milestone 2 is
achieved, an additional 25% of the Shares will vest, with equal additional vesting upon the
achievement of each of the other Milestones.
The achievement of these Milestones shall be determined in the sole discretion of the Company’s
Compensation Committee.
| Milestone | Objective | |
1
|
Achievement of an annualized revenue run rate of $25 million for the Verigene System and assays for two consecutive quarters with a minimum gross margin of 30%. | |
2
|
Achievement of a gross profit margin on product sales of 60% for two consecutive quarters. | |
3
|
Commercial launch of the first infectious disease assay following a board-approved launch plan for a product that has potential annual revenues to Nanosphere of at least $50 million. | |
4
|
Commercial launch of the first ultra-sensitive protein assay following a board-approved launch plan for a product that has potential annual revenues to Nanosphere of at least 50 million. |
3
